Upgrades and Downgrades for Tuesday, 12/21


  • Micron (MU) upgraded by Summit Insights from Hold to Buy
  • ResMed (RMD) upgraded by KeyBanc from Sector Weight to Overweight
  • Richemont (CFRUY) upgraded by Bryan Garnier from Neutral to Buy
  • Straumann (SAUHY) upgraded by Bernstein from Market Perform to Outperform
  • Centrus Energy (LEU) upgraded by Roth Capital from Neutral to Buy
  • KLA Corp. (KLAC) upgraded by Wells Fargo from Equal Weight to Overweight
  • Daimler AG (DDAIF) upgraded by AlphaValue/Baader from Add to Buy
  • BNP Paribas (BNPQY) upgraded by Kepler Cheuvreux from Hold to Buy
  • Neste (NTOIY) upgraded by Kepler Cheuvreux from Hold to Buy
  • Precision Drilling (PDS) upgraded by Piper Sandler from Neutral to Overweight
  • Moneysupermarket.com (MYSRF) upgraded by Citi from Neutral to Buy
  • UMB Financial (UMBF) upgraded by Janney Montgomery Scott from Neutral to Buy
  • Sonoco Products (SON) upgraded by Seaport Global from Neutral to Buy
  • Bank of Montreal (BMO) upgraded by RBC Capital from Sector Perform to Outperform
  • Comerica (CMA) upgraded by Compass Point from Sell to Neutral


  • Arena (ARNA) downgraded by Cantor Fitzgerald from Overweight to Neutral
  • Cigna (CI) downgraded by JPMorgan from Overweight to Neutral
  • HCA Healthcare (HCA) downgraded by JPMorgan from Overweight to Neutral
  • Oracle (ORCL) downgraded by KeyBanc from Overweight to Sector Weightx
  • United Rentals (URI) downgraded by Baird from Outperform to Neutral
  • Herc Holdings (HRI) downgraded by Baird from Outperform to Neutral
  • Bluerock (BRG) downgraded by JMP Securities from Outperform to Market Perform
  • Alibaba (BABA) downgraded by Atlantic Equities from Overweight to Neutral
  • Acadia Pharmaceuticals (ACAD) downgraded by Guggenheim from Buy to Neutral
  • Vir Biotechnology (VIR) downgraded by Baird from Neutral to Underperform
  • Mayne Pharma (MAYNF) downgraded by Citi from Buy to Neutral
  • Josemaria Resources (JOSMF) downgraded by Canaccord from Speculative Buy to Hold
  • Gascoyne Resources (GYYSF) downgraded by Canaccordfrom Buy to Speculative Buy
Wall Street legend warns "A strange day is coming" [sponsor]
A massive and surprising new transition could soon impact the wealth of thousands, while leaving everyone else worse off than before. Click here to learn more.


Upgrades & Downgrades provided by The Fly at http://www.thefly.com.  The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.